首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1672938

標靶藥物傳輸市場：依疾病類型、應用、最終用戶和地區分類

Targeted Drug Delivery Market, By Disease Type, By Application, By End User, By Geography

出版日期: 2025年02月20日 | 出版商:

Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球標靶藥物傳輸市場規模預估為 107.2 億美元，預計到 2032 年將達到 308.8 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 16.3%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	107.2億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	16.30％	2032 年價值預測	308.8億美元

數字。 2025 年標靶藥物傳輸市場佔有率（%）（按地區分類）

標靶藥物傳輸是指將藥物化合物直接輸送到體內的作用目標部位，最大限度地提高治療效果，並最大限度地減少副作用。這涉及將藥物與識別特定細胞表面受體或抗原的靶向配體或部分封裝或結合。這使得藥物載體系統能夠選擇性地針對體內患病細胞或組織，增加藥物在作用部位的生物生物有效性並減少全身副作用。標靶藥物傳輸可使藥物在特異性部位發揮作用，因此對於有效管理各種慢性疾病（包括癌症、心血管疾病和神經系統疾病）具有巨大潛力。

市場動態：

標靶藥物傳輸市場主要受全球慢性病盛行率上升、對療效優異、安全性高的精準藥物的需求增加、以及製藥公司對先進藥物輸送技術研發投入增加的推動。此外，老年人口的增加更容易患慢性病，對奈米藥物和標靶治療的持續研究以及新型標靶藥物製劑的監管核准，都是為市場參與者創造豐厚機會的主要因素。然而，標靶給藥系統的高開發成本、新興國家缺乏適當的臨床研究基礎設施以及標靶藥物配方的複雜性是限制其快速應用的主要挑戰。行業專家和研究人員為開發經濟實惠且穩定的標靶遞送解決方案所做的各種努力可能會在未來幾年有助於克服這些限制。

本研究的主要特點

本報告對全球標靶藥物傳輸市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模（十億美元）和複合年成長率（CAGR%），假設 2024 年為基準年。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
全球標靶藥物傳輸市場的主要企業是根據公司亮點、產品系列、關鍵亮點、業績和策略等參數列出的。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、高階市場策略、市場擴張和行銷策略做出明智的決策。
全球藥物輸送市場迎合了該行業的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過用於分析全球標靶藥物傳輸市場的各種策略矩陣來簡化決策。

公司簡介
- AbbVie Inc.
- Sanofi
- Arrowhead Pharmaceuticals, Inc.
- Baxter International Inc.
- AstraZeneca
- Boston Scientific Corporation
- Depomed, Inc.
- Fraunhofer Gesellschaft Munchen
- Janssen Global Services, LLC
- Luye Pharma Group
- Pfizer Inc.
- Quark Pharmaceuticals Inc.
- Rexahn Pharmaceuticals Inc.
- Savara Inc.
- Roche Holding AG
- Suda Limited
- Taiwan Liposome Company, Ltd.
- Vectura Group PLC

第 10 章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第 11 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI5003

Global Targeted Drug Delivery Market is estimated to be valued at USD 10.72 Bn in 2025 and is expected to reach USD 30.88 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 10.72 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	16.30%	2032 Value Projection:	USD 30.88 Bn

Figure. Targeted Drug Delivery Market Share (%), By Region 2025

Targeted drug delivery refers to the delivery of pharmaceutical compounds directly to the targeted sites of action in the body, thus maximizing the therapeutic effects and minimizing the side effects. It involves the encapsulation or conjugation of drugs with targeting ligands or moieties that recognize specific cell-surface receptors or antigens. This allows the drug carrier system to selectively target the diseased cells or tissues in the body, thereby increasing the bioavailability of drugs at the site of action and reducing systemic side effects. Targeted drug delivery holds tremendous potential for the effective management of various chronic diseases like cancer, cardiovascular ailments, neurological disorders, etc. as it allows site-specific action of drugs.

Market Dynamics:

The targeted drug delivery market is primarily driven by the rising prevalence of chronic diseases globally, boosting the demand for precision medicines with superior efficacy and safety profiles, increasing R&D investments by pharmaceutical companies in advanced drug delivery technologies. Furthermore, the growing geriatric population susceptible to chronic health conditions, ongoing research on nanomedicines and targeted therapies, and regulatory approvals of novel targeted drug formulations are some key factors creating lucrative opportunities for market players. However, high development costs associated with targeted delivery systems, lack of proper infrastructure for clinical research in emerging nations, and complexity of targeted drug formulations are major challenges restraining the rapid adoption. Various initiatives by industry experts and researchers to develop affordable and stable targeted delivery solutions can help overcome these limitations in the coming years.

Key Features of the Study:

This report provides an in-depth analysis of the global targeted drug delivery market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global targeted drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes AbbVie Inc., Sanofi , Arrowhead Pharmaceuticals, Inc., Baxter International Inc., AstraZeneca , Boston Scientific Corporation, Depomed, Inc., Fraunhofer Gesellschaft Munchen, Janssen Global Services, LLC, Luye Pharma Group, Pfizer Inc., Quark Pharmaceuticals Inc., Rexahn Pharmaceuticals Inc., Savara Inc., Roche Holding AG, Suda Limited, Taiwan Liposome Company, Ltd., and Vectura Group PLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global targeted drug delivery market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global targeted drug delivery market.

Detailed Segmentation-

By Disease Type:
- Cardiovascular Diseases
- Pulmonary Diseases
- Infectious Diseases
- Endocrine Diseases
- Oncological Disorders
By Application:
- First Order Targeting
- Second Order Targeting
- Third Order Targeting
By End User:
- Hospitals
- Clinics
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AbbVie Inc.
- Sanofi
- Arrowhead Pharmaceuticals, Inc.
- Baxter International Inc.
- AstraZeneca
- Boston Scientific Corporation
- Depomed, Inc.
- Fraunhofer Gesellschaft Munchen
- Janssen Global Services, LLC
- Luye Pharma Group
- Pfizer Inc.
- Quark Pharmaceuticals Inc.
- Rexahn Pharmaceuticals Inc.
- Savara Inc.
- Roche Holding AG
- Suda Limited
- Taiwan Liposome Company, Ltd.
- Vectura Group PLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Targeted Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Targeted Drug Delivery Market, By Disease Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Cardiovascular Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pulmonary Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Endocrine Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oncological Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Targeted Drug Delivery Market, By Application, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
First Order Targeting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Second Order Targeting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Third Order Targeting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Targeted Drug Delivery Market, By End User, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Targeted Drug Delivery Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- AbbVie Inc.*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Arrowhead Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Baxter International Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boston Scientific Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Depomed, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fraunhofer Gesellschaft Munchen
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Janssen Global Services, LLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Luye Pharma Group
- Pfizer Inc.
- Quark Pharmaceuticals Inc.
- Rexahn Pharmaceuticals Inc.
- Savara Inc.
- Roche Holding AG
- Suda Limited
- Taiwan Liposome Company, Ltd.
- Vectura Group PLC